Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03962790 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Manufacturing Technology
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT03962790 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 95 participants.
The verdict
NCT03962790, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
This study is a multi-site, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear both Test and Control lenses in each eye in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the wearing periods.
Interventions
- DEVICE 1-DAY ACUVUE® MOIST
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2019-05-15 |
| Est. Completion | 2019-07-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03962790
The ClinicalTrials.gov registry entry for NCT03962790 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 1-DAY ACUVUE® MOIST is the first listed.
NCT03962790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03962790 about?
NCT03962790 is a clinical study titled "Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Manufacturing Technology". This study is a multi-site, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear both Test and Control lenses in each eye in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the wearing periods.
What is the current status of trial NCT03962790?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2019-05-15. Estimated completion is 2019-07-10.
What interventions are being tested in trial NCT03962790?
The interventions under investigation include: 1-DAY ACUVUE® MOIST (DEVICE).
Who is sponsoring clinical trial NCT03962790?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.